Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The oropharyngeal microbiota is a complex community of microorganisms inhabiting the throat and mouth. While many are commensal, certain pathogenic bacteria in the oropharyngeal microbiota—such as Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus—can cause significant disease when they overgrow or invade sterile sites (StatPearls, 2023). These pathogens are responsible for a wide range of infections, including pharyngitis, pneumonia, and otitis media (NCBI, 2022). Therapeutic intervention typically involves the use of broad-spectrum or targeted antibiotics that disrupt essential bacterial processes like cell wall synthesis or protein translation (PubMed, 2021). However, targeting these bacteria poses challenges, including the development of antimicrobial resistance and the unintended destruction of beneficial commensal species, which can lead to dysbiosis (Nature Reviews Microbiology, 2021). Effective management requires balancing the elimination of pathogens with the preservation of the host's natural microbial defense systems. The transition from commensalism to pathogenicity is often mediated by environmental stressors or viral infections that alter the local microenvironment (Frontiers in Cellular and Infection Microbiology, 2020). Understanding the specific molecular interactions between these pathogens and the host is crucial for developing more precise antimicrobial therapies.
Inhibition of bacterial cell wall synthesis, protein synthesis, and DNA replication
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic bacteria in the oropharyngeal microbiota.